Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abstract reasoning
adverse drug reaction
Alzheimer's disease
apomorphine
apraxia, constructional
bladder dysfunction
blepharospasm
Brueghel's syndrome
catechol-o-methyltransferase inhibitor
chorea, treatment of
constipation
defecation
dementia
depression
dopamine agonist
dopamine receptor
dopamine receptor, D2
drug interactions
dyskinesia
dystonia, face
entacapone
eosinophilia
Huntington's chorea
hypereosinophilic syndrome(HES)
intellectual deficit
intranasal medication
L-dopa
L-dopa, drug interactions with and side effects of
movement disorder
movement disorder, extrapyramidal
movement disorder, extrapyramidal-treatment of
neurologic disease, diagnoses of
Parkinson disease
Parkinson disease, differential diagnosis of
Parkinson disease, on-off phenomena in
Parkinson disease, transient
Parkinson disease, treatment of
Parkinsonism syndrome
physostigmine
progressive supranuclear palsy
psychological testing
sinemet
single photon emission computed tomography
tolcapone
treatment of neurologic disorder
Weber-Christian's disease
Showing articles 0 to 18 of 18

Amorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease
Neurol 64:392-393, Pot, C., et al, 2005

A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001

Subcutaneous Apomorphine in Parkinson's Disease
Effective Yet Underused, BMJ 316:6411998., , 1998

Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998

Extrapyramidalism in Alzheimer's Disease:Prevalence, Psychiatric and Neuropsychological Correlates
JNNP 57:1503-1509, Merello,M.,et al, 1994

Defecatory Function in Parkinson's Disease:Response to Apomorphine
Ann Neurol 33:490-493, Edwards,L.L.,et al, 1993

123I-iodobenzamide-SPECT Predicts Dopaminergic Responsiveness in patients with De Dovo Parkinsonism
Neurol 42:556-561, Schwarz,J.,et al, 1992

Intranasal Apomorphine in Parkinsonian On-Off Fluctuations
Arch Neurol 49:482-484, vanLaar,T.,et al, 1992

Apomorphine Test for Dopaminergic Response in Pts with Previously Untreated Parkinson's
Arch Neurol 49:1131-1134, Gasser,T.,et al, 1992

Intranasal Apomorphine in Parkinson's Disease
Neurol 41:761-762, Kleedorfer,B.,et al, 1991

Challenge Tests to Predict the Dopaminergic Response in Untreated Parkinson's Disease
Neurol 41:1723-1725, Highes,A.J.,et al, 1991

The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991

Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990

Apomorphine Test to Predict Dopaminergic Responsiveness in Parkinsonian Syndromes
Lancet 336:32-34, Hughes,A.J.,et al, 1990

Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988

Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction
Lancet 2:1451-1453, Christmas,T.J.,et al, 1988

Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979

Apomorphine Hydrochloride-Induced Improvement in Huntington's Chorea
Arch Neurol 35:27, Corsini,G.U.,et al, 1978



Showing articles 0 to 18 of 18